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Objectives: The purpose of this study was to review our experience with delayed open conversion (>30 days) following
endovascular aortoiliac aneurysm repair (EVAR) and to introduce the concept and advantages of endograft retention in
this setting.
Methods: From January 1992 to January 2003, a total of 386 EVARs using a variety of endografts were successfully
deployed. Eleven (2.8%) patients required delayed conversion to open repair at an average of 30 months (range, 10-64).
Data from all patients undergoing both EVAR and open conversion were prospectively collected.
Results: EVARs were performed using grafts made by Talent (4), Vanguard (2,) AneuRx (1), and Surgeon (4).
Conversion to open repair (9 transabdominal, 1 retroperitoneal, 1 transabdominal plus thoracotomy) was performed for
aneurysm rupture in 7 patients (4 type 1 endoleak, 2 type 2 endoleak, 1 aortoenteric fistula) and aneurysm enlargement
in 4 patients (1 type 1 endoleak, 1 type 2 endoleak, 1 type 3 endoleak, 1 endotension). Patients with aneurysm rupture
were treated on an emergent basis. Complete removal of the endograft with supraceliac cross-clamping was performed in
two cases. One patient (rupture) did not survive the operation, and one patient (aortoenteric fistula) died 2 weeks
postoperatively. In the remaining nine cases, the endograft was either completely (1) or partially (6) removed, or left in
situ (2). Supraceliac balloon control (2), supraceliac clamping (1), suprarenal clamping (1), or infrarenal clamping (5) was
used in these cases. All nine of these patients survived the operation. In one procedure in which the endograft was left
intact (endotension), repair was accomplished by exposing the endograft and by placing a standard tube graft over it as
a sleeve. In the second procedure in which the graft was left in situ (rupture), the graft was well incorporated, and
bleeding lumbar arteries were oversewn and the sac was closed tightly over the endograft. In the remaining 7 cases, the
endograft was transected and the proximal portion only (6) or the proximal and distal portions (1) were excised. All
surviving patients continue to do well and remain without complications associated with the endograft remnant at a mean
follow-up of 22 months (range, 3-56) from the time of open conversion and 46 months (range, 10-73) from the time of
original EVAR.
Conclusions: Open repair in the setting of a long-standing endograft offers several unique technical challenges but can be
successfully accomplished in most patients. Preservation of all or part of the endograft is possible in many patients. This
technique simplifies the operative approach and is preferred over complete endograft removal if possible. (J Vasc Surg
2003;38:1191-8.)
Since the first endovascular repair of an abdominal
aortic aneurysm (EVAR) was reported in 1991,1 thousands
of endovascular grafts have been placed worldwide. The
growing popularity of EVAR has proceeded at a dramatic
pace, fueled by improvements in graft manufacture and
design as well as graft availability, operator experience, and
patient demand. Although EVAR can be performed with a
high technical success rate, the midterm and long-term
results are uncertain, and recipients of these grafts require
close, ongoing, life-long follow-up.2 Although most en-
dograft failures can be treated endovascularly, in some
cases, the development of endoleak with aneurysm enlarge-
ment, aneurysm enlargement without demonstrable en-
doleak, aortoenteric fistula, graft migration, or rupture may
necessitate conversion to an open repair on an elective or
sometimes emergent basis. With the ever-increasing num-
ber of these grafts being placed, the need for a systematic
approach to problems associated with them, including their
removal and conversion to open repair when necessary, will
become increasingly important.
Preservation of the proximal end of an endograft has
been previously reported.3 In this setting preservation of
the endograft was necessary because the surgeon was un-
able to remove the suprarenal and pararenal portions of the
endograft. We propose that in many cases preservation of
part of the endograft is a virtue in that it avoids damage in
the native arteries as well as buttresses the suture lines for
the new graft anastomosis, while avoiding the risk of type 1
endoleak beside the retained segment of the endograft.
From the Division of Vascular Surgery, Department of Surgery, Montefiore
Medical Center and the Albert Einstein College of Medicine.
Supported by grants from the James Hilton Manning and Emma Austin
Manning Foundation and the Anna S. Brown Trust.
Competition of interest: none.
Presented at the Seventeenth Annual Meeting of the Eastern Vascular
Society, New York, NY, May 1-4, 2003.
Reprint requests: Evan C Lipsitz, MD, Montefiore Medical Center, Division
of Vascular Surgery-Vascular Laboratory, 111 E 210th St, Bronx, NY
10467 (e-mail: Elipsitz@aol.com).
Copyright © 2003 by The Society for Vascular Surgery.
0741-5214/2003/$30.00  0
doi:10.1016/j.jvs.2003.09.012
1191
Because of these concerns and the technical difficulties
associated with the late removal of endografts, we reviewed
our experience with delayed open conversion (30 days)
after endovascular aortoiliac aneurysm repair (EVAR) and
introduce the concept and advantages of endograft reten-
tion in this setting.
METHODS
From January 1992 through January 2003, a total of
386 EVARs were successfully deployed for the treatment of
aortoiliac aneurysms. The initial technical success rate for
graft placement during this period was 97%, and the imme-
diate conversion rate was 1% (3 of 386). Several different
endografts were used in this experience, including 21 EVT
or Ancure (EVT/Guidant, Menlo Park, Calif), 16 Van-
guard (Boston Scientific, Natick, Mass), 49 Talent
(Medtronic, Sunnyvale, Calif), 24 Excluders (WL Gore,
Flagstaff, Ariz), 78 AneuRx (Medtronic, Sunnyvale, Calif),
3 Corvita (Schneider/Boston Scientific, Natick, Mass), 35
Zenith (Cook Inc., Bloomington, IN), 5 Quantum (Cor-
dis, Warren, NJ), and 155 Montefiore Endovascular Graft
System (MEGS) grafts. Bifurcated industry-made devices
and surgeon-made aortouni-iliac or aortounifemoral grafts
were placed by standard methods.4,5 Data from all patients
undergoing both EVAR and open conversion were pro-
spectively collected. Patients were followed with serial com-
puterized tomography scans and routine physical examina-
tions at 1, 6, and 12 months postoperatively and yearly
thereafter. Indications for delayed conversion included
rupture, aortoenteric fistula, and aneurysm enlargement of
2 cm with or without demonstrable endoleak. Those
patients requiring conversion to open repair at greater than
30 days after EVAR were identified for further analysis.
RESULTS
There were 11 (2.8%) patients who required delayed
conversion to open repair at an average of 30 months
(range, 10-64) from the time of the original procedure
(Table). Ten of the original EVARs were performed elec-
tively, and one was performed for aneurysm rupture. Nine
delayed conversions were performed at our institution and
two (patient nos. 1 and 2) were performed at other institu-
tions. The mean age of the patients undergoing delayed
conversion was 76  8.4 years, and all were men. Associ-
ated comorbidities in this group included coronary artery
disease (left ventricular ejection fraction20%, recent con-
gestive heart failure, unstable angina, areas of myocardium
at risk on nuclear imaging studies, or nonreconstructible
disease on coronary angiography) (82%), chronic obstruc-
tive pulmonary disease (forced expiratory volume at 1
second 50%, predicted, home oxygen requirement)
(18%), diabetes mellitus (27%), hypertension (90%), and
chronic renal insufficiency (creatinine 3, dialysis) (9%).
Two (18%) of the patients were on warfarin for auricular
fibrillation. There were 49 patients in the overall series with
isolated iliac artery aneurysms and 2 patients (nos. 5 and 8,
Table) in the treatment group with isolated iliac artery
aneurysms. The mean aneurysm size at the time of EVAR
was 6.9 cm (range, 6-10) for all patients and 7.0 cm (range,
6-10) when excluding patients with isolated iliac artery
aneurysms. The mean aneurysm size at the time of delayed
conversion was 8.2 cm (range, 6-12) for all patients and 8.4
cm (range, 6-12) excluding patients with isolated iliac
artery aneurysms. Nine patients had an increase in aneu-
rysm size, and two patients had stable aneurysm size. There
were no significant differences in patient demographics or
Patients undergoing delayed conversion to open repair following EVAR
Patient Endograft
Time to
conversion,
(mo) Indication Clamp placement Findings
Portion of
endograft left
in situ
1 MEGS 55 Rupture Supraceliac Proximal type 1 endoleak None
2 Talent 10 Aortoenteric
fistula
Thoracic aorta Aortoenteric fistula from
jejunum to bare stent
of graft
None
3 Vanguard 28 Type 2 endoleak Infrarenal Type 2 endoleak None
4 Vanguard 64 Type 3 endoleak
Migration
Suprarenal Type 3 endoleak Distal
5 MEGS (iliac
graft)
18 Rupture Supraceliac balloon,
then infrarenal
clamp
Ruptured hypograstric
aneurysm
Distal
6 Talent 21 Proximal type 1 Supraceliac balloon,
then infrarenal
clamp
Proximal type 1 endoleak
repaired with AneuRx
cuff, covered bilateral
renal arteries
Distal
7 Talent 38 Rupture Infrarenal Graft migration Distal
8 MEGS (iliac
graft)
17 Rupture Infrarenal Proximal type 1 endoleak Distal
9 AneuRx 26 Rupture Infrarenal Type 1 endoleak Distal
10 MEGS (for
rupture)
15 Enlarging AAA Graft Endotension Entire graft
11 Talent 31 Rupture Supraceliac Type 2 endoleak Entire graft
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follow-up between all patients undergoing EVAR and
those patients who required delayed conversion other than
the percentage of men which was 87% in the overall group.
Of the seven patients presenting with rupture, all presented
with pain and six with hypotension. Of the two patients
who died, one patient (no. 1) had extensive blood loss both
preoperatively and intraoperatively (because of extensive
scarring and difficult graft removal), and the other patient
(no. 2) died of multisystem organ failure several days after
extra-anatomic bypass.
Four of the 11 patients (36%) underwent a total of six
secondary procedures for the treatment of endoleaks before
undergoing open conversion. One patient (no. 10) under-
went translumbar decompression for an expanding aneu-
rysm and endotension without demonstrable endoleak. By
way of a translumbar approach a needle was placed into the
aneurysm sac. Pressures were elevated without evidence of
endoleak. A large amount of gelatinous material was with-
drawn from the sac with resulting decrease in aneurysm size
and intrasac pressure. This material subsequently re-accu-
mulated, and aneurysm diameter increased, necessitating
repair. Another patient (no. 6) required stent placement
within the limb of a bifurcated graft that subsequently
thrombosed, and a femorofemoral bypass was performed.
This patient ultimately developed a type 1 endoleak and
underwent delayed conversion when attempt at endovas-
cular repair with a proximal AneuRx cuff failed, resulting in
coverage of the renal arteries. Patient no. 3 underwent coil
embolization of a patent iliolumbar artery by way of a
hypogastric artery approach for the treatment of type 2
endoleak. Patient no. 4 had a dislocation of the contralat-
eral limb of a bifurcated graft (distal type 1 endoleak)
treated with two Vanguard iliac extensions to re-seat the
graft in the common iliac artery. He later developed a
separation at the junction of these limbs, and a single
bridging AneuRx graft was placed across the limbs. Com-
pletion angiography at that procedure suggested a small
leak from the proximal ipsilateral limb, and a second An-
euRx graft was placed across this area. None of these four
patients undergoing secondary interventions presented
with rupture.
EVARs in this group were performed using grafts made
by Talent (4), Vanguard (2) AneuRx (1), and Surgeon (4).
Conversion to open repair (9 transabdominal, 1 retroperi-
toneal, 1 transabdominal plus thoracotomy) was performed
for aneurysm rupture in 7 patients (4 type 1 endoleak, 2
type 2 endoleak, 1 aortoenteric fistula) and aneurysm en-
largement in 4 patients (1 type 1 endoleak, 1 type 2
endoleak, 1 type 3 endoleak, 1 endotension). All proce-
dures were performed under general anesthesia. Patients
with aneurysm rupture were treated on an emergent basis.
Two of the four type 1 endoleaks (patient nos. 1 and 7)
were diagnosed preoperatively, one patient refused inter-
vention and one patient was scheduled for repair but rup-
tured prior. One of the two type 2 endoleaks (patient no.
11) was diagnosed preoperatively, and the patient was
scheduled for surgery but ruptured prior. The aortoenteric
fistula was not diagnosed before surgery. Whether this
fistula was due to erosion by the graft or primary ulcer
disease is not clear. Both patients whose endoleaks were
diagnosed preoperatively were asymptomatic when diag-
nosed and were scheduled for repair within 2 weeks of
diagnosis.
Complete removal of the endograft with supraceliac
cross-clamping was performed in two cases. One of these
patients (no. 1) had a known type 1 endoleak but refused
intervention, went on to rupture, and did not survive the
operation because of a massive myocardial infarction. The
other patient (no. 2) had an aortoenteric fistula and died 2
weeks postoperatively after graft explant and axillobifemo-
ral bypass. In the remaining 9 cases, the endograft was
either completely (1) or partially (6) removed or left in situ
(2). Supraceliac balloon control (2), supraceliac clamping
(1), suprarenal clamping (1), or infrarenal clamping (5) was
used in these cases. All nine of these patients survived the
operation. Distal arterial control was achieved by using
clamps on the common iliac arteries, although Fogarty
balloon control can also be used. In the setting of an
unsupported graft (MEGS), the graft itself was clamped
within the aneurysm sac.
In one procedure performed for endotension, repair
was accomplished by dividing the surgeon-made aor-
tounifemoral (MEGS) graft within the aneurysm sac. A
standard tube graft was then placed over the endograft (as
a sleeve). The endograft was then sutured back together,
restoring continuity and flow. The standard graft was then
sutured both proximally and distally, incorporating the
endograft in the anastomosis proximally. Thus, flow was
maintained through the endograft and buttressed by the
standard graft. The second procedure in which the graft
was left in situ was performed for rupture. At operation the
graft was noted to be well incorporated both proximally
and distally. Four bleeding lumbar arteries were oversewn,
and the sac was closed tightly over the endograft. In the
remaining 7 cases, the endograft was transected, and the
proximal portion only (6) or the proximal and distal por-
tions (1) were excised. Proximal graft was removed in those
cases in which proximal stent migration was present. This
migration facilitated extraction of the proximal stent from
the neck. When the proximal graft was removed, a standard
aortic graft was placed between the proximal neck and the
remaining endograft (Fig 1, 2). To avoid future distal type
1 endoleaks, the distal end of the new graft (standard) was
sewn to the residual endografts as well as to the iliac artery
orifices.
All surviving patients continue to do well and remain
without complications associated with the endograft rem-
nant. One patient had a small myocardial infarction 1
month after the procedure (no. 7), and one patient devel-
oped a small bowel obstruction that necessitated lysis of
adhesions 2 months postoperatively (no. 4). There were no
episodes of renal failure excluding one patient who was
already on dialysis. The perioperative morbidity and mor-
tality rate for all patients was 27%. Patients with any or all
graft left in situ had a perioperative morbidity of 13%,
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whereas patients whose grafts were completely excised had
a perioperative morbidity of 67%.
Mean length of follow-up from the time of delayed
conversion was 22 months (range, 3-56) and from the time
of the original EAVR was 46 months (range, 10-73). None
of the 11 patients undergoing delayed conversion were lost
to follow-up. Operation time for the delayed conversions
was 6.4  2.3 hours with an average blood loss of 3800 
2400 mL. The mean supraceliac and/or suprarenal isch-
emia time for the six patients requiring this approach was
15 minutes (range, 8-27). The mean length of stay for the
nine patients undergoing successful delayed conversion was
9.9 days (range, 5-19).
DISCUSSION
The late removal of aortic endografts is technically
challenging, especially when performed in the acute set-
ting. The overall delayed conversion rate for patients un-
dergoing EVAR has been estimated to be between 0.6%
and 4.5%.6-15 The mortality rate seen in this series is
comparable to that of other series and underscores the
difficulty in performing these procedures.3,8,11 .Despite the
fact that there was good compliance with the follow-up
regimen, the delayed conversion rates cited above and the
number of patients presenting with rupture suggest that
more frequent surveillance, especially in patients who have
had EVAR more than 1 year ago, may be warranted. In
Fig 1. Limb of endograft (patient no. 9) being cut at iliac orifice (A) and residual graft limbs at iliac orifices (B).
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addition, the presence of certain cues, eg, failure to achieve
aneurysm shrinkage, should indicate the need for more
frequent imaging than indicated by the specific graft pro-
tocol.
The exact approach to the late removal of endografts
depends on several factors, including the type and condi-
tion of the endograft originally placed as well as the pres-
ence of suprarenal stents and/or hooks or barbs; the pres-
ence of any additional grafts, cuffs, or coils placed as
secondary interventions; the condition of proximal and
distal fixation points and how intact they are; the current
aneurysm morphology; the presence of periaortic scarring
or inflammation; and, most importantly, the urgency of the
repair. Additionally, several studies have documented peri-
graft reaction with at least some incorporation of the en-
dografts, especially at the proximal portion.16,17 Although
not sufficient to provide secure long-term fixation,18 these
changes contribute to the difficulties associated with late
endograft removal. Simple traction or traction with com-
pression of the graft might not be enough to permit graft
retrieval. It could be necessary to cut either the proximal
bare stents or the proximal graft itself, including stents, and
wire cutters should be available for this purpose. En-
dografts with stents located on the outside of the graft
material may also be more difficult to remove than those
with stents located inside or contained within the graft
Fig 2. Standard graft being anastomosed to residual endograft (arrows) and iliac orifices (A) and complete repair (B)
(patient no. 9). Proximal anastomosis (single wide arrow at left) and distal anastomoses (arrows at right) are shown.
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material because of the inflammatory reaction incited by
the stents. Additionally, when stents are positioned outside
the graft, these stents may cause more damage to the native
arteries during removal than would be the case if only the
graft material were exposed to the native artery. We have
found that the use of a compliant balloon placed in the
supraceliac aorta by way of a brachial or femoral approach
can decease the time until proximal artic control is
achieved. It also reduces the need for what can be difficult
dissection of the suprarenal and/or supraceliac aorta. It
may also reduce the need for an extensive arteriotomy.
Once the graft has been removed or infrarenal control has
been obtained, the balloon can be deflated, reperfusing the
visceral vessels.
In our series all patients but one were converted by
using a midline transperitoneal approach. One patient (no.
2) required a left thoracotomy in addition to laparotomy
for supraceliac control because of dense adhesions in the
upper abdomen. The patient who was converted using a
retroperitoneal approach (no. 6) had an occlusion of the
right limb of the endograft with a functioning femorofemo-
ral bypass. Although we prefer a midline transperitoneal
incision for these cases, the retroperitoneal approach does
facilitate exposure of the suprarenal and, if required, su-
praceliac aorta. The disadvantages of the retroperitoneal
approach in this setting include limited exposure to the
right iliac system. This limitation could, however, be easily
overcome by making an incision in the right retroperito-
neum. Additionally, should the orifice of the right renal
artery be damaged during explant, control and exposure of
the artery could be difficult by way of this approach.
Although excision of the proximal endograft has been
the focus of most reports about delayed conversions, re-
moval of the distal endograft may also be prohibitive.
Removal of the distal limbs often requires significant trac-
tion8 and/or probing of the iliac arteries which can render
these arteries unsuitable as target vessels for outflow.
Although complete removal of the endograft and re-
placement with a standard graft during delayed conversion
is preferable, we believe that in many cases complete or even
partial endograft removal might be unnecessary and might
unduly complicate the procedure, adding to its morbidity.
In only 1 of 9 patients who survived the perioperative
period was the endograft completely excised. We can spec-
ulate as to whether partial or complete graft preservation
could have improved the outcome in any of the three
patients with complete endograft removal (67% morbidity
and mortality) relative to the group with partial or complete
endograft preservation (13% morbidity and mortality). But
to answer the question adequately with meaningful statis-
tical analysis would require a larger series. However, in this
small series no significant differences were found between
the two groups with regard to hypotension, free versus
contained rupture, estimated blood loss, comorbidities,
transfusions, operative time, number of days in the inten-
sive care unit, or length of stay between the two groups of
patients.
In cases in which the standard graft is anastomosed to
the endograft, we recommend incorporating the native
artery into the suture line (Fig 2). One potential concern is
that suturing to an endograft might not provide as durable
an anastomosis as suturing to standard grafts. An additional
measure in cases in which a potion of the endograft is left in
situ is to close the aneurysm sac tightly over the entire new
graft complex to prevent any kinking, twisting, or buckling
of the graft that could lead to limb dislodgement.
In the case of the patient with endotension (no. 10),
the graft (MEGS) remained firmly seated both proximally
(suprarenal balloon-expandable stent) and distally (endolu-
minal anastomosis). The repair was designed to further
secure the proximal anastomosis, to protect against the
development of type 1 endoleak, and to eliminate the effect
of any fluid translocation from the graft material into the
aneurysm sac. Patient no. 11 had a rupture because of a type
2 endoleak. Although currently we would recommend
branch coil embolization or translumbar embolization as
an initial therapy, this patient’s endoleak could not be
adequately characterized preoperatively, and in the setting
of an enlarging aneurysm he was scheduled for surgery. At
operation the endograft was extremely well seated, and
attempts to remove all or part of it would likely have
resulted in significant trauma to the vessels involved as well
as complicated the operation in this patient with multiple
comorbidities.
Open repair in the setting of a long-standing endograft
offers several unique technical challenges but can be suc-
cessfully accomplished in most patients. With the large
numbers of endografts being implanted worldwide the
problem of delayed conversion to open repair will only
increase in importance. The basic principles and techniques
of endograft explantation should be familiar to all vascular
surgeons. Although the approach to each patient requiring
delayed conversion must be individualized, preservation of
all or part of the endograft is possible in many patients. This
technique simplifies the operative approach, reduces the
amount of dissection required, and is often preferable to
complete endograft removal.
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DISCUSSION
Dr Ronald M. Fairman (Philadelphia, Pa). This is a very
interesting paper, and I commend your whole group for looking at
this very carefully. I have a number of questions. My understanding
of the manuscript is that you’ve presented 11 delayed conversions:
7 were ruptures and 4 were due to progressive enlargement. Two
of the 11 patients died perioperatively. I would be interested to
know what endograft types were in those two patients who died
and whether that mattered. You commented in the paper that the
mortality in the group where you completely excised the graft was
67%, so I’m interested to know whether perhaps were they supra-
renal grafts versus infrarenal grafts?
I really like your approach that you have taken, which is a
selective approach to managing these complications. I have been
impressed with the explants that I have done that, in fact, there is
very little incorporation, though, regardless of whatever the graft
type is, whether it is an exoskeleton or an endoskeleton, they seem
to slide right out of the sac when I open the sac. Have you seen
much incorporation with any of these cases that you’ve done?
How did the ruptures present? Are we protected? Do we have
more time to intervene on ruptures than with a standard aortic
rupture? Are there any differences?
If I sort out the numbers correctly, it looks as if 4 of the 49
Talent grafts that you implanted required conversion. That’s about
an 8% or 9% incidence, and it seems to me to not bode very well for
the Talent device. That certainly is very different from our experi-
ence. It’s different from every other Talent report that I’ve heard.
And I’m just curious whether you can shed any more light on that?
Dr Evan C. Lipsitz. Thank you Dr Fairman. Of the two
patients who died, one had a surgeon-made graft (MEGS), and the
other had a Talent graft. In both patients, although the grafts were
suprarental, it was more the severity of the presentation than the
type of graft that contributed to the mortality. One of the patients
had a known endoleak and refused intervention. His aneurysm
increased in size from 7 to 12 cm, and he presented to the hospital
hypotensive and with extensive blood loss. He did, in fact, have
good incorporation of the proximal Palmaz stent of the MEGS
graft and required a supraceliac clamp for what was a difficult graft
extrication.
The other patient had an aortoenteric fistula and had more
septic-related complications than anything else. Although in terms
of those two patients, it is probably a case of sicker patients just
doing worse, one could say that the presence of suprarenal stents
that have not migrated added complexity.
Regarding your second question about the graft sliding out, in
many cases we also did not find significant incorporation. In several
cases we were able to clamp infrarenally because the grafts had
slipped down. In several other cases, even when we required a
supraceliac balloon, the graft was relatively easy to remove.
Whether this will be different as the industry increases and im-
proves proximal fixation devices such as suprarenal stents, hooks,
and barbs, these kinds of cases are going to become more difficult,
although I hope that we will have to do them less often. One issue
is that in the absence of graft migration, it is difficult to assess
preoperatively how difficult it will be to remove the graft. The
presence of an exoskeleton will likely not increase incorporation
but may increase trauma to the vessel when removed.
As to whether or not we are protected, I think some early
literature suggested that we might be. In our series several patients
presented with “contained” rupture, which enabled them to return
to our hospital for repair. That, in and of itself, may represent a
somewhat selected group of patients. Overall, I do not think the
presence of an endograft is protective nor that the time frame for
repair should be any different than for de novo rupture, but again,
the approach must be individualized.
Finally, regarding the relatively high delayed conversion rate
for the Talent grafts (which was also seen in the Vanguard grafts),
I did not do a graft-specific analysis because the length of follow-up
for each of the grafts is really quite different.
Dr Dhiraj M. Shah (Albany, NY). Dr Lipsitz, I enjoyed your
presentation. Were the seven patients who had ruptures lost to
follow-up, or did you have any premonition that something was
happening with any of these patients, like endoleak or slow migra-
tion? Could the ruptures have beeen prevented?
Dr Lipsitz. Thank you, Dr Shah. In the majority of these
patients we did not have any indication of impending rupture on
follow-up. One patient had a known type I endoleak and refused
further intervention. Another patient with migration of the prox-
imal graft had a CAT scan and angiogram and was being scheduled
for explant, but had a rupture prior to his elective repair. A third
patient had aneurysm enlargement with a type 2 endoleak and was
being medically optimized in the hospital prior to repair when his
rupture occurred. As an example of the remaining cases, I showed
a 12-month CT without enlargement in a patient who suddenly, at
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